26 March 2026: The annual general meeting of Aker BioMarine ASA will be held on
Tuesday 28 April 2026 at 13:00 CEST.
The meeting will be conducted as a virtual meeting only, and voting will be
handled online during the meeting. Information about log-in details for the
meeting is available in the notice of
the general meeting. For further information regarding participation, please go
to www.akerbiomarine/agm.
No pre-registration is needed for attending online, but attendees must be logged
in before the meeting starts. Deadline for registration of advance votes and
proxies is 24 April 2026 at 16:00 CEST.
Please find attached the following documents
- Notice and Proxy forms for the Annual General Meeting 2026
- Proposed Resolutions for the Annual General Meeting 2026
- Management Remuneration Report 2025
- Proposal from the Nomination Committee
All documents to be processed in the meeting are available on
www.akerbiomarine/agm.
For further information, please contact
Christopher Robin Vinter, SVP Finance
Mobile: +47 911 60 820
Email: Christopher.vinter@akerbiomarine.com
This information is subject to the disclosure requirements pursuant to Section
5-12 the Norwegian Securities Trading Act.
About Aker BioMarine
Aker BioMarine is a leading human health and nutrition innovator that develops
krill-derived products for consumer health and nutrition. Krill is a natural,
powerful, and health-promoting source of nutrients from the pristine waters of
Antarctica, and Aker BioMarine has a unique position in its industry. The
ingredient portfolio consists of Superba Krill Oil, Lysoveta, Revervia, and PL+,
as well as the consumer brand, Kori Krill. The innovative approach also extends
into the spin-offs AION (reduce and recycle plastic waste across industries) and
Understory (a protein brand). Aker BioMarine is listed on the Oslo Stock
Exchange (AKBM). More information is available at www.akerbiomarine.com.